Common triggers may include: Other causes include nutrition deficiencies, endocrine disorders, and dramatic weight loss
Neurogastroenterol Motil 20(6):649659 Nslund E, Skogar S, Efendic S, Hellstrm PM (2002) Glucagon-like peptide-1 analogue LY315902: effect on intestinal motility and release of insulin and somatostatin
Among patients with and those without a history of heart failure, SGLT2 inhibitors reduced the incidence of hospitalization for heart failure (37)
Use Aetnas online portal or mobile app to check the drug formulary (list of covered drugs)
If an official label becomes available in a jurisdiction, that label will define approved uses, dosing, contraindications, warnings, and monitoring requirements
This same mechanism has garnered GLP-1 attention as a promising potential treatment for reducing alcohol cravings